LUX-Breast 1; An Open Label, Randomised Phase III Trial of BIBW 2992 and Vinorelbine Versus Trastuzumab and Vinorelbine in Patients With Metastatic HER2-overexpressing Breast Cancer Failing One Prior Trastuzumab Treatment
收藏DataCite Commons2025-11-14 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00003604/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
To investigate the efficacy and safety of BIBW 2992 in combination with vinorelbine i.v. chemotherapy as treatment in patients with HER2-overexpressing, metastatic breast cancer, who failed one prior trastuzumab (Herceptin®) treatment
提供机构：
Vivli
创建时间：
2019-04-12
